Marmarou Christina R, Walker Susan A, Davis C Lynn, Povlishock John T
Department of Anatomy and Neurobiology, Virginia Commonwealth University Health Center, Virginia Commonwealth University, Richmond, VA 23298, USA.
J Neurotrauma. 2005 Oct;22(10):1066-80. doi: 10.1089/neu.2005.22.1066.
Traumatic axonal injury (TAI) following traumatic brain injury (TBI) contributes to morbidity and mortality. TAI involves intra-axonal changes assumed to progress to impaired axonal transport (IAT), disconnection, and axonal bulb formation. Immunocytochemical studies employing antibodies to amyloid precursor protein (APP), a marker of IAT and RMO14, a marker of neurofilament compaction (NFC), have shown that TAI involves both NFC and IAT, with the suggestion that NFC leads to IAT. Recently, new data has suggested that NFC may occur independently of IAT. The objective of this study was to determine quantitatively the precise relationship between NFC and IAT. Following TBI, rats were studied at 30 min, 3 h, and 24 h. Using single-label immunocytochemistry employing the antibodies RM014, APP, or a combined labeling strategy targeting APP/RMO14 in aggregate, the immunoreactive (IR) profiles were counted in the corticospinal tract (CSpT) and medial lemniscus (ML). In the CSpT, the number of axons demonstrating RMO14-IR approximated the number of axons showing APP-IR, with the APP-IR population showing a significant increase over 24 h (p < 0.05). The sum of both single-label counts equaled the aggregate APP/RMO14 numbers, demonstrating little relationship between NFC and IAT. In the ML, 75% of fibers demonstrated a separation of APP-IR and NFC-IR; however, 25% of the ML fibers showed co-localization of APP-IR and RMO14. The results of these studies indicate that, in the majority of damaged axons, NFC is not associated with IAT. Our findings argue for the use of multiple markers when evaluating the extent of TAI or the efficacy of therapies targeting the treatment of TAI.
创伤性脑损伤(TBI)后的创伤性轴突损伤(TAI)会导致发病和死亡。TAI涉及轴突内的变化,这些变化被认为会发展为轴突运输受损(IAT)、轴突离断和轴突球形成。使用针对淀粉样前体蛋白(APP,IAT的标志物)和RMO14(神经丝致密化(NFC)的标志物)的抗体进行的免疫细胞化学研究表明,TAI涉及NFC和IAT,提示NFC会导致IAT。最近,新数据表明NFC可能独立于IAT发生。本研究的目的是定量确定NFC和IAT之间的精确关系。TBI后,在30分钟、3小时和24小时对大鼠进行研究。使用针对抗体RM014、APP的单标记免疫细胞化学或针对APP/RMO14的联合标记策略,在皮质脊髓束(CSpT)和内侧丘系(ML)中计数免疫反应性(IR)谱。在CSpT中,显示RMO14-IR的轴突数量与显示APP-IR的轴突数量相近,APP-IR群体在24小时内显著增加(p<0.05)。两个单标记计数的总和等于总的APP/RMO14数量,表明NFC和IAT之间关系不大。在ML中,75%的纤维显示APP-IR和NFC-IR分离;然而,25%的ML纤维显示APP-IR和RMO14共定位。这些研究结果表明,在大多数受损轴突中,NFC与IAT无关。我们的研究结果支持在评估TAI的程度或针对TAI治疗的疗法疗效时使用多种标志物。